| Accession Number: | 0001209191-22-041499 |
| Date: | 2022-07-05 |
| Issuer: | ADICET BIO, INC. (ACET) |
| Original Submission Date: |
AFTAB BLAKE
C/O ADICET BIO, INC.
200 CLARENDON STREET, FLOOR 6
BOSTON, MA 02116
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2022-07-05 | S | 1,363 | d | $14.50 | 52,903 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
| f2 | includes 1,363 shares purchased under the issuer's amended and restated 2018 employee stock purchase plan on june 30, 2022 in a transaction that is exempt under rule 16b-3(c) and 16b-3(d). |
